Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans

Pine, Samuel O.; Kublin, James G.; Hammer, Scott M.; Borgerding, Joleen; Yunda Huang; Casimiro, Danilo R.; McElrath, M. Juliana
April 2011
PLoS ONE;2011, Vol. 6 Issue 4, p1
Academic Journal
The results of the recent Step Study highlight a need to clarify the effects of pre-existing natural immunity to a vaccine vector on vaccine-induced T-cell responses. To investigate this interaction, we examined the relationship between preexisting Ad5 immunity and T-cell cytokine response profiles in healthy, HIV-uninfected recipients of MRKAd5 HIV-1 gag vaccine (HVTN 050, ClinicalTrials.gov #NCT00849732). Participants were grouped by baseline Ad5 neutralizing antibody titer as either Ad5-seronegative (titer ≤18; n = 36) or Ad5-seropositive (titer >200; n = 34). Samples from vaccine recipients were analyzed for immune responses to either HIV-1 Gag peptide pools or Ad5 empty vector using an ex vivo assay that measures thirty cytokines in the absence of long-term culture. The overall profiles of cytokine responses to Gag and Ad5 had similar combinations of induced Th1- and Th2-type cytokines, including IFN-γ, IL-2, TNF-α, IP-10, IL-13, and IL-10, although the Ad5-specific responses were uniformly higher than the Gag-specific responses (p<0.0001 for 9 out of 11 significantly expressed analytes). At the peak response time point, PBMC from Ad5-seronegative vaccinees secreted significantly more IP-10 in response to Gag (p = 0.008), and significantly more IP-10 (p = 0.0009), IL-2 (p = 0.006) and IL-10 (p = 0.05) in response to Ad5 empty vector than PBMC from Ad5-seropositive vaccinees. Additionally, similar responses to the Ad5 vector prior to vaccination were observed in almost all subjects, regardless of Ad5 neutralizing antibody status, and the levels of secreted IFN-γ, IL-10, IL-1Ra and GM-CSF were blunted following vaccination. The cytokine response profile of Gag-specific T cells mirrored the Ad5-specific response present in all subjects before vaccination, and included a number of Th1- and Th2-associated cytokines not routinely assessed in current vaccine trials, such as IP-10, IL-10, IL-13, and GM-CSF. Together, these results suggest that vector-specific humoral responses may reduce vaccine-induced T-cell responses by previously undetected mechanisms.


Related Articles

  • An HIV Vaccine - Evolving Concepts. Johnston, Margaret I.; Fauci, Anthony S. // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2073 

    The article examines the development of a vaccine for protection against the human immunodeficiency virus (HIV). According to the author, a vaccine that induces strong T-cell mediated immune responses in the absence of broadly neutralizing antibodies may prove beneficial even if the HIV...

  • Alternative Effector-Function Profiling Identifies Broad HIV-Specific T-Cell Responses in Highly HIV-Exposed Individuals Who Remain Uninfected. Ruiz-Riol, Marta; Llano, Anuska; Ibarrondo, Javier; Zamarreño, Jennifer; Yusim, Karina; Bach, Vanessa; Mothe, Beatriz; Perez-Alvarez, Susana; Fernandez, Marco A.; Requena, Gerard; Meulbroek, Michael; Pujol, Ferran; Leon, Agathe; Cobarsi, Patricia; Korber, Bette T.; Clotet, Bonaventura; Ganoza, Carmela; Sanchez, Jorge; Coll, Josep; Brander, Christian // Journal of Infectious Diseases;Mar2015, Vol. 211 Issue 6, p936 

    The characterization of host immune responses to human immunodeficiency virus (HIV) in HIV controllers and individuals with high exposure but seronegativity to HIV (HESN) is needed to guide the development of effective preventive and therapeutic vaccine candidates. However, several technical...

  • Editorial [Hot Topic: Mechanisms of Cell Death: Biomedical Implications (Executive Editor: E. Ottaviani)]. Ottaviani, Enzo // Current Pharmaceutical Design;Jan2008, Vol. 14 Issue 3, p197 

    Cell death is a basic element occurring not only in the normal organism functioning but also in many forms of aging and pathologies. The reviews here collected focus on the important role that the different types of cell death, or the interplay among them, can play in many forms of aging and...

  • Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. Muyanja, Enoch; Ssemaganda, Aloysius; Ngauv, Pearline; Cubas, Rafael; Perrin, Helene; Srinivasan, Divya; Canderan, Glenda; Lawson, Benton; Kopycinski, Jakub; Graham, Amanda S.; Rowe, Dawne K.; Smith, Michaela J.; Isern, Sharon; Michael, Scott; Silvestri, Guido; Vanderford, Thomas H.; Castro, Erika; Pantaleo, Giuseppe; Singer, Joel; Gillmour, Jill // Journal of Clinical Investigation;Jul2014, Vol. 124 Issue 7, p3147 

    Background. Defining the parameters that modulate vaccine responses in African populations will be imperative to design effective vaccines for protection against HIV, malaria, tuberculosis, and dengue virus infections. This study aimed to evaluate the contribution of the patient-specific immune...

  • Application of Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1. Aghasadeghi, Mohammad Reza; Salmani, Ali Sharifat; Sadat, Seyed Mehdi; Javadi, Foozieh; Memarnejadian, Arash; Vahabpour, Rouhoullah; Zabihollahi, Rezvan; Moshiri, Arfa; Siadat, Seyed Davar // Current HIV Research;Dec2011, Vol. 9 Issue 8, p630 

    Despite the worldwide efforts made in the field of HIV vaccine development, an efficient AIDS vaccine strategy is still vague. Virus-like particles (VLPs) are one of the introduced aspects for HIV vaccine development since the non-replicative nature of HIV VLPs, resulting from the lack of viral...

  • Peripheral Blood Lymphocyte Subsets in Acute Human Melioidosis. Ramsay, S. C.; Ketheesan, N.; Norton, R.; Watson, A.-M.; LaBrooy, J. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2002, Vol. 21 Issue 7, p566 

    This article discusses the pathology of acute human melioidosis. Melioidosis is a gram-negative bacterial infection caused by Burkholderia pseudomallei. Although it often occurs in individuals with coexistent disease predisposing to immunosuppression, it also occurs in apparently normal...

  • Genetic approaches to the study of cytokine regulation of mucosal immunity. Ramsay, Alistair J. // Immunology & Cell Biology;Dec1995, Vol. 73 Issue 6, p484 

    Efforts to design effective mucosal vaccines have been hampered by an incomplete understanding of factors controlling the development of mucosal immunity. It is now clear, however, that T cell-derived cytokines play a major role. Recent developments in 'gene knockout' technology have allowed the...

  • The immune response during acute HIV-1 infection: clues for vaccine development. McMichael, Andrew J.; Borrow, Persephone; Tomaras, Georgia D.; Goonetilleke, Nilu; Haynes, Barton F. // Nature Reviews Immunology;Jan2010, Vol. 10 Issue 1, p11 

    The early immune response to HIV-1 infection is likely to be an important factor in determining the clinical course of disease. Recent data indicate that the HIV-1 quasispecies that arise following a mucosal infection are usually derived from a single transmitted virus. Moreover, the finding...

  • Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses. Machitani, Mitsuhiro; Yamaguchi, Tomoko; Shimizu, Kahori; Sakurai, Fuminori; Katayama, Kazufumi; Kawabata, Kenji; Mizuguchi, Hiroyuki // Pharmaceutics;Sep2011, Vol. 3 Issue 3, p338 

    The major limitation of the clinical use of replication-incompetent adenovirus (Ad) vectors is the interference by innate immune responses, including induction of inflammatory cytokines and interferons (IFN), following in vivo application of Ad vectors. Ad vector-induced production of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics